TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,695,062 | -61.1% | 972,602 | -33.1% | 1.42% | -53.7% |
| Q2 2023 | $22,344,653 | -36.5% | 1,454,730 | -7.0% | 3.07% | -32.3% |
| Q1 2023 | $35,165,252 | +299.9% | 1,563,595 | +274.0% | 4.54% | +236.5% |
| Q4 2022 | $8,792,622 | -14.4% | 418,099 | +0.3% | 1.35% | -37.7% |
| Q3 2022 | $10,268,000 | -65.7% | 416,729 | -66.3% | 2.16% | -71.7% |
| Q2 2022 | $29,928,000 | +33.3% | 1,235,151 | +41.8% | 7.64% | +5.0% |
| Q1 2022 | $22,444,000 | +297.1% | 870,918 | +378.3% | 7.28% | +141.0% |
| Q4 2021 | $5,652,000 | – | 182,103 | – | 3.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 235 | $2,113 | 0.00% |